Risks of red blood cell alloimmunization in transfusion‐dependent β‐thalassemia in Oman: a 25‐year experience of a university tertiary care reference center and a literature review

β‐Thalassemia is a common hemoglobinopathy in the Arabian Peninsula. Red blood cell (RBC) transfusion is a cornerstone for its management, but can create significant challenges including RBC alloimmunization. Herein, we examine alloimmunization risk factors in Omani patients with transfusion‐dependent β‐thalassemia. Existing literature is summarized.

[1]  Shahira Elshafie,et al.  Study of red blood cell alloimmunization risk factors in multiply transfused thalassemia patients: role in improving thalassemia transfusion practice in Fayoum, Egypt , 2016, Transfusion.

[2]  Z. Alfirevic,et al.  Red blood cell alloimmunization , 2016 .

[3]  A. Pathare,et al.  Red Cell Alloimmunization to Rhesus Antigen Among Pregnant Women Attending a Tertiary Care Hospital in Oman. , 2016, Oman medical journal.

[4]  K. Davari,et al.  Study of alloimmunization and autoimmunization in Iranian β-thalassemia major patients , 2016, Asian journal of transfusion science.

[5]  J. Callum,et al.  Consent for blood transfusion: Do patients understand the risks and benefits? , 2014, Transfusion medicine.

[6]  K. Eliaçık,et al.  Frequency of red cell allo- and autoimmunization in patients with transfusion-dependent beta thalassemia and affecting factors. , 2014, The Turkish journal of pediatrics.

[7]  S. Daar,et al.  Transfusion therapy and alloimmunization in Thalassemia Intermedia: a 10 year experience at a tertiary care university hospital. , 2014, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[8]  N. Marwaha,et al.  Alloimmunization and autoimmunization in transfusion dependent thalassemia major patients: Study on 319 patients , 2014, Asian journal of transfusion science.

[9]  A. Kamal,et al.  Predictors of red cell alloimmunization in multitransfused Egyptian patients with β-thalassemia. , 2014, Archives of pathology & laboratory medicine.

[10]  L. Pierelli,et al.  Red blood cell alloimmunization in sickle cell disease and in thalassaemia: current status, future perspectives and potential role of molecular typing , 2014, Vox sanguinis.

[11]  A. Verma,et al.  Red Blood Cell Antibodies in Thalassemia Patients in Northern India: Risk Factors and Literature Review , 2014, Indian Journal of Hematology and Blood Transfusion.

[12]  M. Cappellini,et al.  Guidelines for the Management of Transfusion Dependent Thalassaemia (TDT) , 2014 .

[13]  R. Jain,et al.  Detection and Identification of Red Cell Alloantibodies in Multiply Transfused Thalassemia Major Patients: A Prospective Study , 2014, Indian Journal of Hematology and Blood Transfusion.

[14]  Jang-Jih Lu,et al.  Red blood cell alloimmunisation among Chinese patients with β-thalassaemia major in Taiwan. , 2013, Blood transfusion = Trasfusione del sangue.

[15]  A. Thompson,et al.  Challenges of alloimmunization in patients with haemoglobinopathies , 2012, British journal of haematology.

[16]  C. Lee,et al.  Clinically significant red blood cell antibodies in chronically transfused patients: a survey of Chinese thalassemia major patients and literature review , 2012, Transfusion.

[17]  R. Ware,et al.  Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management. , 2012, Blood.

[18]  Mohsen Saleh Elalfy,et al.  Red blood cell alloimmunization in transfusion‐dependent Egyptian patients with thalassemia in a limited donor exposure program , 2012, Transfusion.

[19]  Richa Gupta,et al.  Alloimmunization to red cells in thalassemics: emerging problem and future strategies. , 2011, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[20]  M. Maghsudlu,et al.  Blood Transfusion and Alloimmunization in Patients with Thalassemia: Multicenter Study , 2011, Pediatric hematology and oncology.

[21]  A. Kaddah,et al.  Alloimmunization and Erythrocyte Autoimmunization in Transfusion-dependent Egyptian Thalassemic Patients , 2011, Journal of pediatric hematology/oncology.

[22]  E. Neufeld,et al.  Red cell alloimmunization in a diverse population of transfused patients with thalassaemia , 2011, British journal of haematology.

[23]  C. V. van Buskirk,et al.  Red blood cell phenotype matching for various ethnic groups , 2011, Immunohematology.

[24]  C. Chaudhari.  Red Cell Alloantibodies in Multiple Transfused Thalassaemia Patients. , 2011, Medical journal, Armed Forces India.

[25]  S. Sloan,et al.  Survey of transfusion policies at US and Canadian children's hospitals in 2008 and 2009 , 2010, Transfusion.

[26]  S. Ragab,et al.  Red cell alloimmunization and autoantibodies in Egyptian transfusion-dependent thalassaemia patients , 2010, Archives of medical science : AMS.

[27]  M. Pujani,et al.  Alloimmunization and red cell autoimmunization in multitransfused thalassemics of Indian origin , 2010, Hematology.

[28]  S. Joshi,et al.  Development of blood transfusion service in Sultanate of Oman , 2010, Asian journal of transfusion science.

[29]  H. Rafatpanah,et al.  Alloimmunization among transfusion-dependent thalassemia patients , 2009, Asian journal of transfusion science.

[30]  N. Avent.  Large‐scale blood group genotyping – clinical implications , 2009, British journal of haematology.

[31]  M. Karimi,et al.  RBC alloimmunization in blood transfusion‐dependent β‐thalassemia patients in southern Iran , 2007, International journal of laboratory hematology.

[32]  D. J. West,et al.  CHALLENGING HEALTH CARE SYSTEM SUSTAINABILITY IN OMAN , 2007 .

[33]  G. Daniels,et al.  Blood group antibodies and their significance in transfusion medicine. , 2007, Transfusion medicine reviews.

[34]  H. Rosline,et al.  Red cell immunization in multiply transfused Malay thalassemic patients. , 2006, The Southeast Asian journal of tropical medicine and public health.

[35]  D. Liang,et al.  Alloimmunization among patients with transfusion‐dependent thalassemia in Taiwan , 2006, Transfusion medicine.

[36]  Matthew W. Darlison,et al.  Standards for the Clinical Care of Children and Adults with Thalassaemia in the UK , 2005 .

[37]  A. Brand,et al.  Alloimmunization to red blood cell antigens after universal leucodepletion. A regional multicentre retrospective study , 2005, British journal of haematology.

[38]  S. Al-Shemmari,et al.  RBC alloimmunization and autoimmunization among transfusion‐dependent Arab thalassemia patients , 2003, Transfusion.

[39]  N. Blumberg,et al.  WBC reduction of RBC transfusions is associated with a decreased incidence of RBC alloimmunization , 2003, Transfusion.

[40]  A. Al-Riyami,et al.  Genetic Blood Disorders Survey in the Sultanate of Oman. , 2003, Journal of tropical pediatrics.

[41]  A. Al-Riyami,et al.  A community-based study of common hereditary blood disorders in Oman. , 2001, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.

[42]  Y. Lau,et al.  Alloimmunization in Hong Kong southern Chinese transfusion-dependent thalassemia patients. , 2001, Blood.

[43]  E. Vichinsky,et al.  Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly asian descent. , 2000, Blood.

[44]  T. Huisman,et al.  Molecular Characterization of α-Thalassemia Determinants, β-Thalassemia Alleles, and βs Haplotypes among Kuwaiti Arabs , 1994 .

[45]  T. Huisman,et al.  Molecular characterization of alpha-thalassemia determinants, beta-thalassemia alleles, and beta S haplotypes among Kuwaiti Arabs. , 1994, Acta haematologica.

[46]  J. Peristeri,et al.  Red Cell Alloantibodies in Patients with Thalassemia , 1990, Vox sanguinis.

[47]  A. Karaklis,et al.  Alloimmunization to Red Cell Antigens in Thalassemia: Comparative Study of Usual versus Better‐Match Transfusion Programmes , 1987, Vox sanguinis.

[48]  J. White,et al.  Red cell genetic abnormalities in Peninsular Arabs: sickle haemoglobin, G6PD deficiency, and alpha and beta thalassaemia. , 1986, Journal of medical genetics.

[49]  A. Zanella,et al.  Red cell alloantibodies in thalassemia major , 1985, Transfusion.

[50]  M. Adinolfi,et al.  Frequency of Antibodies to Various Antigenic Determinants in Polytransfused Patients with Homozygous Thalassaemia in Greece , 1971, Vox sanguinis.